About Xanthoastrocytoma: Tarik Tihan. We also show a study about the identification of BRAF V600E, TERT, and IDH2 mutations in PXA

Tarik Tihan, MD, PhD Professor of Clinical Pathology, Step 3  Pathology  School of Medicine University of California, San Francisco, (My goal is to develop a better understanding of the critical elements for histological classification of primary CNS neoplasms with specific emphasis on pediatric brain tumors, their distinctive subtypes and prognostic markers for each subtype. Our observations contributed to the understanding of biological behavior and molecular features in some tumors such as pilomyxoid astrocytomas. My laboratory actively collaborates with many colleagues from the Brain Tumor Research Center, UCSF, and scientists from national and international).Gives us this interesting studies about xanthoastrocytoma. We appreciate your contribution and researches about xanthoastrocytoma,
Tarik Tihan nos ha enviado estos dos artículos que tratan sobre el xantoastrocitoma. Agradecemos su aportación e interés.
https://drive.google.com/file/d/1HpBBTOR5yLOvYZXfU-2y7saJHrnBIUW2/view?usp=sharing

https://drive.google.com/file/d/10mr6bfXRHmhVfi0kGDUpGsDj9L8reRgU/view?usp=sharing


We also show a study about the identification of BRAF V600E, TERT, and IDH2 mutations in PXA:

https://www.ncbi.nlm.nih.gov/pubmed/30240866